Literature DB >> 26691635

Autonomic dysfunction, immune regulation, and multiple sclerosis.

Juan Manuel Racosta1, Kurt Kimpinski2.   

Abstract

OBJECTIVE: To review existing evidence regarding interactions between the autonomic nervous system and the immune system functions in multiple sclerosis.
METHODS: We reviewed the literature regarding new insights linking autonomic dysfunction to immune deregulation in multiple sclerosis, with particular focus on the specific influence of sympathetic and parasympathetic dysfunction on inflammatory and neurodegenerative processes.
RESULTS: Autonomic dysfunction is common in multiple sclerosis, representing a significant cause of disability. Several connections between pathologic immune pathways and the autonomic nervous system function were found.
CONCLUSIONS: Autonomic dysfunction may enhance inflammatory and neurodegenerative pathways that are of major importance in multiple sclerosis. Autonomic dysfunction can present with highly variable manifestations. Sympathetic and parasympathetic dysfunction displays different patterns in multiple sclerosis, with specific impact on inflammation and neurodegeneration.

Entities:  

Keywords:  Autonomic dysfunction; Clinical manifestations; Immune regulation; Inflammation; Multiple sclerosis; Neurodegeneration

Mesh:

Year:  2015        PMID: 26691635     DOI: 10.1007/s10286-015-0325-7

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  44 in total

1.  Association of smoking with risk of multiple sclerosis: a population-based study.

Authors:  Sreeram V Ramagopalan; Joshua D Lee; Irene M Yee; Colleen Guimond; Anthony L Traboulsee; George C Ebers; A Dessa Sadovnick
Journal:  J Neurol       Date:  2013-03-02       Impact factor: 4.849

2.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

3.  A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.

Authors:  Samia J Khoury; Brian C Healy; Pia Kivisäkk; Vissia Viglietta; Svetlana Egorova; Charles R G Guttmann; Josiah F Wedgwood; David A Hafler; Howard L Weiner; Guy Buckle; Sandra Cook; Susheel Reddy
Journal:  Arch Neurol       Date:  2010-09

4.  Periodic hyperthermia and abnormal circadian temperature rhythm in a patient with multiple sclerosis.

Authors:  J E Martinez-Rodriguez; E Munteis; J Roquer
Journal:  Mult Scler       Date:  2006-08       Impact factor: 6.312

5.  Hypothalamic lesions in multiple sclerosis.

Authors:  I Huitinga; C J De Groot; P Van der Valk; W Kamphorst; F J Tilders; D F Swaab
Journal:  J Neuropathol Exp Neurol       Date:  2001-12       Impact factor: 3.685

6.  Therapy with interferon-beta modulates endogenous catecholamines in lymphocytes of patients with multiple sclerosis.

Authors:  Mauro Zaffaroni; Franca Marino; Raffaella Bombelli; Emanuela Rasini; Marta Monti; Marco Ferrari; Angelo Ghezzi; Giancarlo Comi; Sergio Lecchini; Marco Cosentino
Journal:  Exp Neurol       Date:  2008-09-12       Impact factor: 5.330

7.  HPA axis activity in multiple sclerosis correlates with disease severity, lesion type and gene expression in normal-appearing white matter.

Authors:  Jeroen Melief; Stella J de Wit; Corbert G van Eden; Charlotte Teunissen; Jörg Hamann; Bernard M Uitdehaag; Dick Swaab; Inge Huitinga
Journal:  Acta Neuropathol       Date:  2013-06-28       Impact factor: 17.088

8.  The cholinergic anti-inflammatory system limits T cell infiltration into the neurodegenerative CNS, but cannot counteract complex CNS inflammation.

Authors:  Eva-Maria Nicolussi; Sigismund Huck; Hans Lassmann; Monika Bradl
Journal:  Neurobiol Dis       Date:  2009-03-31       Impact factor: 5.996

9.  Differential effect of selective block of alpha 2-adrenoreceptors on plasma levels of tumour necrosis factor-alpha, interleukin-6 and corticosterone induced by bacterial lipopolysaccharide in mice.

Authors:  G Haskó; I J Elenkov; V Kvetan; E S Vizi
Journal:  J Endocrinol       Date:  1995-03       Impact factor: 4.286

Review 10.  Reflex control of immunity.

Authors:  Kevin J Tracey
Journal:  Nat Rev Immunol       Date:  2009-06       Impact factor: 53.106

View more
  13 in total

Review 1.  Immune and autonomic nervous system interactions in multiple sclerosis: clinical implications.

Authors:  Mario Habek
Journal:  Clin Auton Res       Date:  2019-04-08       Impact factor: 4.435

2.  Autonomic Nervous System Response to Stressors in Newly Diagnosed Patients with Multiple Sclerosis.

Authors:  Miroslav Vlcek; Adela Penesova; Richard Imrich; Milada Meskova; Martina Mravcova; Lucia Grunnerova; Alexandra Garafova; Monika Sivakova; Peter Turcani; Branislav Kollar; Daniela Jezova
Journal:  Cell Mol Neurobiol       Date:  2017-06-21       Impact factor: 5.046

Review 3.  Autonomic function and brain volume.

Authors:  Juan M Racosta; Kurt Kimpinski
Journal:  Clin Auton Res       Date:  2016-08-27       Impact factor: 4.435

4.  Abnormal venous postural control: multiple sclerosis-specific change related to gray matter pathology or age-related neurodegenerative phenomena?

Authors:  Dejan Jakimovski; Matthew Topolski; Kana Kimura; Karen Marr; Sirin Gandhi; Deepa P Ramasamy; Niels Bergsland; Jesper Hagemeier; Bianca Weinstock-Guttman; Robert Zivadinov
Journal:  Clin Auton Res       Date:  2018-08-17       Impact factor: 4.435

5.  β-Adrenoceptor Blockade Moderates Neuroinflammation in Male and Female EAE Rats and Abrogates Sexual Dimorphisms in the Major Neuroinflammatory Pathways by Being More Efficient in Males.

Authors:  Ivan Pilipović; Zorica Stojić-Vukanić; Ivana Prijić; Nebojša Jasnić; Jelena Djordjević; Gordana Leposavić
Journal:  Cell Mol Neurobiol       Date:  2022-07-08       Impact factor: 5.046

Review 6.  Autonomic dysfunction in idiopathic hypersomnia: an overlooked association and potential management.

Authors:  Nour Adra; Manasa Reddy; Hrayr Attarian; Ashima S Sahni
Journal:  J Clin Sleep Med       Date:  2022-03-01       Impact factor: 4.062

7.  Autonomic Nervous System Function in Newly Diagnosed Multiple Sclerosis: Association With Lipid Levels and Insulin Resistance.

Authors:  M Hardoňová; P Šiarnik; M Siváková; M Suchá; M Vlček; R Imrich; P Turčáni; A Havranová; Ž Rádiková; I Žitňanová; Z Dean; A Penesová; B Kollár
Journal:  Physiol Res       Date:  2021-10-30       Impact factor: 1.881

8.  Autonomic symptom burden is an independent contributor to multiple sclerosis related fatigue.

Authors:  Magdalena Krbot Skorić; Luka Crnošija; Ivan Adamec; Barbara Barun; Tereza Gabelić; Tomislav Smoljo; Ivan Stanić; Tin Pavičić; Ivan Pavlović; Jelena Drulović; Tatjana Pekmezović; Mario Habek
Journal:  Clin Auton Res       Date:  2018-09-12       Impact factor: 4.435

Review 9.  Wearable biosensors to monitor disability in multiple sclerosis.

Authors:  Michael J Bradshaw; Samantha Farrow; Robert W Motl; Tanuja Chitnis
Journal:  Neurol Clin Pract       Date:  2017-08

10.  Cardiac Autonomic Dysfunction in Myasthenia Gravis and Relapsing-Remitting Multiple Sclerosis-A Pilot Study.

Authors:  Łukasz Rzepiński; Monika Zawadka-Kunikowska; Julia L Newton; Paweł Zalewski
Journal:  J Clin Med       Date:  2021-05-18       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.